Our publications

Building the foundation for tomorrow’s medicines

In 2006, BioNTech’s co-founders, Ugur Sahin and Özlem Türeci, published their first peer-reviewed paper in the journal Blood: “Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.” This marked a pivotal moment in their systematic efforts to address key scientific challenges such as improving the stability and efficacy of RNA, which began in the late 1990s.

The 2006 publication was just the beginning. Since then, BioNTech’s co-founders, along with their teams, have published numerous scientific papers spanning various therapeutic modalities. These publications reflect their unwavering vision to translate science into survival by developing innovative therapies and vaccines aimed at improving the health of people worldwide. From foundational discoveries to cutting-edge advancements, BioNTech’s research continues to push the boundaries of medical science, driving progress toward improving or establishing new standards of care.